Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02112851 · ClinicalTrials.gov registry record · NA
Processed Orange and the Glycemic Response
A NA study, sponsored by PepsiCo Global R&D.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT02112851 is a NA study that has completed, run by PepsiCo Global R&D. The registered enrollment target is 38 participants.
The verdict
NCT02112851, a NA study, has completed, sponsored by PepsiCo Global R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
Randomized, placebo controlled, double blind, postprandial crossover study in male subjects. 3 intervention arms, consisting of a control (Product A), a low dose processed whole orange (Product B) and a high dose processed whole orange (Product C), to determine the effect of the interventions on the primary endpoint of postprandial glycemia. Secondarily, plasma insulin concentrations will be quantified.
Interventions
- OTHER Orange flavored beverage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2014-03-07 |
| Est. Completion | 2016-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02112851
The ClinicalTrials.gov registry entry for NCT02112851 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is PepsiCo Global R&D, which has 47 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Orange flavored beverage is the first listed.
NCT02112851 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02112851 about?
NCT02112851 is a clinical study titled "Processed Orange and the Glycemic Response". Randomized, placebo controlled, double blind, postprandial crossover study in male subjects. 3 intervention arms, consisting of a control (Product A), a low dose processed whole orange (Product B) and a high dose processed whole orange (Product C), to determine the effect of the interventions on the...
What is the current status of trial NCT02112851?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2014-03-07. Estimated completion is 2016-01.
What interventions are being tested in trial NCT02112851?
The interventions under investigation include: Orange flavored beverage (OTHER).
Who is sponsoring clinical trial NCT02112851?
This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.